Law Quad, Univeristy of Michigan
Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
May 5, 2016 7:00 am
It is well-recognized that Crohn’s disease is associated with delays in the onset and progression of puberty with the potential for stunted growth, impaired bone accrual, and diminished quality of life.
Now, a study (MD DeBoer et al. J Pediatr 2016; 171: 146-52) shows that initiation of anti-tumor necrosis factor α (anti-TNFα) treatment results in a rapid increase in sex hormone and gonadotropin levels.
In 72 adolescents, this observational study followed levels of sex hormones, gonadotropin levels, dual-energy x-ray absorptiometry, along with cytokine/inflammatory markers at initiation of anti-TNFα therapy, at 10 weeks and at 12 months.
Key findings:
My take (from the authors): This study suggests that “systemic inflammation suppresses gonadotropin-stimulated production of sex hormones” and that treatment of this inflammation with anti-TNFα agents allows rapid resumption normal production.
Related blog posts:
Law Quad, Univeristy of Michigan
Posted by gutsandgrowth
Categories: inflammatory bowel disease
Tags: anti-TNF therapy, constitutional pubertal and growth delay, Crohn's disease, dexa, infliximab, puberty, sex hormones, short stature
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] Related blog post: Here’s Why Biologic Therapy for Crohn’s Helps Adolescents … […]
By Why some kids are short & understanding linear growth | gutsandgrowth on June 15, 2016 at 7:01 am
[…] Here’s Why Biologic Therapy for Crohn’s Helps Adolescents Grow […]
By Growth in Inflammatory Bowel Disease: Better Late Than Never | gutsandgrowth on February 4, 2021 at 7:00 am
[…] Here’s Why Biologic Therapy for Crohn’s Disease Helps Adolescents Grow […]
By Should We Worry About Osteopenia in Children with Crohn’s Disease? | gutsandgrowth on March 5, 2021 at 7:00 am